We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
+6.27%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$17.9B
AUM Growth
-$597M
(-3.2%)
Cap. Flow
-$1.32B
Cap. Flow
% of AUM
-7.36%
Top 10 Holdings %
Top 10 Hldgs %
8.81%
Holding
1,709
New
345
Increased
450
Reduced
603
Closed
311
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$146M |
| 2 |
Apple
AAPL
|
+$129M |
| 3 |
Tesla
TSLA
|
+$110M |
| 4 |
Medtronic
MDT
|
+$104M |
| 5 |
Verizon
VZ
|
+$102M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$181M |
| 2 |
Microsoft
MSFT
|
+$177M |
| 3 |
Comcast
CMCSA
|
+$173M |
| 4 |
Adobe
ADBE
|
+$163M |
| 5 |
Broadcom
AVGO
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.34% |
| 2 | Healthcare | 14.31% |
| 3 | Consumer Discretionary | 12.9% |
| 4 | Industrials | 11.52% |
| 5 | Financials | 10.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Emcor
EME
$37B
| $19.2M | 0.11% |
129,327
+11,886
| +10% | +$1.69M |
|
277
Waters Corp
WAT
$40.8B
| $19M | 0.11% |
55,519
-17,161
| -24% | -$5.43M |
|
278
Toast
TOST
$19.3B
| $19M | 0.11% |
1,052,528
+48,205
| +5% | +$906K |
|
279
Casey's General Stores
CASY
$30.9B
| $18.9M | 0.11% |
84,459
-5,515
| -6% | -$1.26M |
|
280
Gartner
IT
$11.5B
| $18.9M | 0.11% |
+56,219
| New | +$18.1M |
|
281
Barclays
BCS
$94.4B
| $18.8M | 0.1% |
2,408,303
+979,148
| +69% | +$7.14M |
|
282
Amdocs
DOX
$6.08B
| $18.6M | 0.1% |
204,224
-73,022
| -26% | -$6.21M |
|
283
Manulife Financial
MFC
$73.2B
| $18.5M | 0.1% |
1,036,287
+837,100
| +420% | +$14.3M |
|
284
Bilibili
BILI
$7.32B
| $18.3M | 0.1% |
+774,329
| New | +$12.3M |
|
285
Coca-Cola Europacific Partners
CCEP
$47.3B
| $18.3M | 0.1% |
330,887
+103,801
| +46% | +$5.21M |
|
|
GTLS
286
DELISTED
Chart Industries
GTLS
| $18.2M | 0.1% |
158,227
+155,031
| +4,851% | +$24.9M |
|
287
Weatherford International
WFRD
$6.69B
| $18.2M | 0.1% |
357,533
+159,131
| +80% | +$6.56M |
|
288
Chubb
CB
$134B
| $17.9M | 0.1% |
81,127
-175,736
| -68% | -$36.6M |
|
289
Lincoln Electric
LECO
$15.5B
| $17.9M | 0.1% |
123,810
+1,121
| +0.9% | +$157K |
|
290
Royalty Pharma
RPRX
$26.2B
| $17.8M | 0.1% |
+449,291
| New | +$18.8M |
|
291
Takeda Pharmaceutical
TAK
$55.6B
| $17.6M | 0.1% |
1,128,372
+173,345
| +18% | +$2.42M |
|
292
Vertex Pharmaceuticals
VRTX
$134B
| $17.6M | 0.1% |
+60,891
| New | +$18.6M |
|
293
KB Home
KBH
$3.46B
| $17.5M | 0.1% |
550,766
+140,763
| +34% | +$4.19M |
|
294
Loews
L
$23.2B
| $17.5M | 0.1% |
300,616
+40,391
| +16% | +$2.25M |
|
295
Dominion Energy
D
$59.6B
| $17.4M | 0.1% |
283,500
+272,992
| +2,598% | +$17.1M |
|
296
Brown-Forman Class B
BF.B
$12.8B
| $17.2M | 0.1% |
261,577
-112,470
| -30% | -$7.63M |
|
297
Amgen
AMGN
$225B
| $17.1M | 0.1% |
65,037
-422,371
| -87% | -$113M |
|
298
Celsius Holdings
CELH
$6.93B
| $16.9M | 0.09% |
487,983
-512,748
| -51% | -$16.7M |
|
299
Super Micro Computer
SMCI
$23.3B
| $16.8M | 0.09% |
2,040,950
+724,670
| +55% | +$5.52M |
|
300
UiPath
PATH
$7.91B
| $16.7M | 0.09% |
1,310,259
+448,875
| +52% | +$5.55M |
|
Similar funds
CS
VAI
Voloridge Investment Management's Q4 2022 Portfolio in Review
As of Q4 2022, Voloridge Investment Management held 1,709 positions worth $17.9B, down 3.2% from $18.5B the previous quarter. Its ten largest holdings account for 8.8% of the portfolio.
Voloridge Investment Management withdrew a net $1.32B in Q4 2022, closing 311 positions and reducing 603 holdings. Its most notable exit was Berkshire Hathaway Class B, an estimated $181M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Voloridge Investment Management opened a new position in Edwards Lifesciences worth $142M.
- Voloridge Investment Management's largest Q4 2022 buy was Edwards Lifesciences: 1,898,822 shares worth $142M.
- Voloridge Investment Management added most to Tesla in Q4 2022, an estimated $110M increase.
- Voloridge Investment Management's biggest Q4 2022 reduction was Microsoft, cutting an estimated $177M.
- Voloridge Investment Management fully exited Berkshire Hathaway Class B in Q4 2022, selling an estimated $181M.
- Voloridge Investment Management's ten largest holdings make up 8.8% of its $17.9B portfolio in Q4 2022.
- Voloridge Investment Management opened 345 new positions and closed 311 in Q4 2022.
- Voloridge Investment Management's portfolio value fell 3.2% quarter-over-quarter to $17.9B.
Based on Voloridge Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.